Cepeginterferon alfa-2b in the treatment of chronic myeloproliferative diseases.
Melikyan AL, Subortseva IN, Gilyazitdinova EA, Koloshejnova TI, Pustovaya EI, Egorova EK, Kovrigina AM, Sudarikov AB, Abdullaev AO, Lomaia EG, Siordiya NT, Zaritskey AY, Savchenko VG.
Melikyan AL, et al. Among authors: zaritskey ay.
Ter Arkh. 2018 Aug 17;90(7):23-29. doi: 10.26442/terarkh201890723-29.
Ter Arkh. 2018.
PMID: 30701919
Clinical Trial.